In 2018, 36 of the 65 newly approved medications in Germany were biopharmaceuticals – an unprecedented fifty-eight percent.
24 Suchergebnisse für: medical biotech
As Europe’s largest medical biotech market, Germany continues to attract foreign investment thanks to its many established companies and dynamic start-up sector. Gradian Diagnostics’ recent acquisition of Molzym is a fine example of international matchmaking, facilitated by Germany Trade & Invest.
German biotech continues to grow, representing an opportunity for foreign capital.
Germany is Europe’s number one healthcare market by volume: Patients, manufacturers and providers power a life science industry composed of thriving medical technology, pharmaceuticals, medical biotechnology, and digital health sectors.
Industrial electromobility picks up the pace in Saxony-Anhalt.
Germany’s healthcare market is the largest in Europe, and the reputation of its universities and research institutes is second to none. Now the country is increasingly starting to exploit its potential as an innovation hub for life sciences.
“The similarities between German and Chinese Greenfield investors often outweigh the differences” – that’s the conclusion drawn by Dennis Wilkens, Germany Trade & Invest’s China director. And that’s why lots of Chinese companies are setting up shop in Germany.
How Pfizer’s coronavirus vaccine breakthrough was achieved together with a previously obscure Mainz-based firm, BioNTech, which is now worth over a billion euros
Throughout 2020, this website featured more than 350 articles and videos about Germany as a business and high-tech location. Below is a list so that you can catch up on anything you might have missed.
Germany’s market for medical technology – worth EUR 38 billion in 2019 – was already one of the largest in the world before the coronavirus. But the arrival of Covid-19 brought exponential growth in demand for German medical solutions.
Suchergebnis nicht zufriedenstellend? Versuche es mal mit einem Wort oder einer anderen Schreibweise